Equities Analysts Offer Predictions for RLAY Q2 Earnings
Relay Therapeutics, Inc. (NASDAQ:RLAY – Free Report) – Investment analysts at Leerink Partnrs issued their Q2 2025 earnings per share (EPS) estimates for Relay Therapeutics in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens anticipates that the company will earn ($0.51) per share for the quarter. The consensus estimate for Relay […]
![Equities Analysts Offer Predictions for RLAY Q2 Earnings](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/relay-therapeutics-inc-logo-1200x675.png?v=20210329152018&w=240&h=240&zc=2)